Bluejay Diagnostics (BJDX) Common Equity (2020 - 2026)
Bluejay Diagnostics (BJDX) recorded Common Equity of $9.41 million in Q2 2026, up 78.0% from $5.29 million a year earlier and up 125.2% from the prior quarter.
Powered by 
Analysis
Bluejay Diagnostics (BJDX) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Bluejay Diagnostics reported Common Equity of $5.98 million, up 4.3% from FY2024.
- Across earlier years, Common Equity came in at $5.73 million in FY2024 (+97.9%), $2.89 million in FY2023 (-74.9%), $11.54 million in FY2022 (-43.4%) and $20.38 million in FY2021.
- The Q2 2026 figure is the highest quarterly Common Equity since Q4 2022.
- On a year-over-year basis, Common Equity has increased for three consecutive quarters, with growth averaging 19.2% over the last eight quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 97.9% in Q4 2024, against a decline of 74.9% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $4.18 million (Q1 2026), $5.98 million (Q4 2025) and $3.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 52.69 Bn |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 51.76 Bn |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 52.59 Bn |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 18.30 Bn |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 23.99 Bn |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 25.17 Bn |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 10.72 Bn |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 24.42 Bn |
| 10 | Bluejay Diagnostics | 1.86 Mn | 1.86 Mn | - | 9.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.41 Mn |
| Mar 31, 2026 | 4.18 Mn |
| Dec 31, 2025 | 5.98 Mn |
| Sep 30, 2025 | 3.69 Mn |
| Jun 30, 2025 | 5.29 Mn |
| Mar 31, 2025 | 3.87 Mn |
| Dec 31, 2024 | 5.73 Mn |
| Sep 30, 2024 | 7.16 Mn |
| Jun 30, 2024 | 8.64 Mn |
| Mar 31, 2024 | 3.37 Mn |
| Dec 31, 2023 | 2.89 Mn |
| Sep 30, 2023 | 5.21 Mn |
| Jun 30, 2023 | 6.38 Mn |
| Mar 31, 2023 | 9.16 Mn |
| Dec 31, 2022 | 11.54 Mn |
| Sep 30, 2022 | 13.81 Mn |
| Jun 30, 2022 | 16.66 Mn |
| Mar 31, 2022 | 18.49 Mn |
| Dec 31, 2021 | 20.38 Mn |
| Sep 30, 2021 | -1.08 Mn |
API Access
Bluejay Diagnostics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BJDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BJDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BJDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();